Cannabinoid Receptor 2 Gene Polymorphism and the Risk of Developing Rheumatoid Arthritis in Lebanese Patients.

Evidence supports a role of cannabinoid receptor 2 (CB2) in regulating the immune response. Some variations in the CB2 receptor gene (CB2) were linked to the susceptibility of developing rheumatoid arthritis (RA). The aim of this study is to assess the relationship between rs2501431 and the risk of developing RA in Lebanese patients. A total of one hundred five Lebanese RA patients and one hundred five controls participated in the study. was genotyped and analyzed. Using test, our results show that the CC genotype was the most common (47.6%, <0.00001) and that the C allele highly predominated (64%, <0.00001) in the RA group compared to the control group. The relative odds ratio show that carriers of the CC genotype have more than 13-fold risk of developing RA as compared to TT. Our results suggest that the rs2501431 variant of gene can be considered as a risk factor for RA development, and thus implicate the potential targeting of CB2 receptor for the treatment of RA.